Search
Google AI-Powered Pharmaceutical Development Poised to Achieve Milestone with Upcoming First-in-Human Trial
1 day ago /
Read about 0 minute
Author：小编
Isomorphic Labs, a spin-off from Google's DeepMind, has announced, through its President and DeepMind's Chief Commercial Officer Colin Murdoch, that the company's AI-designed anti-cancer drug is set to commence its first-in-human clinical trial. Murdoch emphasized that this marks a significant milestone in drug development, signifying the progression of AI-designed medications into clinical testing phases. As part of this endeavor, Isomorphic Labs is actively recruiting personnel to propel this project forward. Building on DeepMind's pioneering AlphaFold research, the company is dedicated to leveraging AI to expedite the drug discovery process.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
